Association of pelvic endometriosis with alopecia universalis, autoimmune thyroiditis and multiple sclerosis

An adult Caucasian female developed a previously unreported association of pelvic endometriosis (PE) with the triad of alopecia universalis (AU), autoimmune thyroiditis (AT) and multiple sclerosis (MS). Molecular human leukocyte antigen (HLA)-tissue typing of this subject showed the presence of the DR(2) 15 and DR(3) 17 alleles, which are associated to an increased risk of MS and AT, respectively. Clinical onset of AT followed withdrawal of corticosteroid treatment for AU, whereas MS become clinically evident after withdrawal from long-term estroprogestin therapy for PE. This clinical case is presented to discuss the autoimmune origin of PE, its possible association with multiple autoimmune disorders as well as the effect of other factors, such as administration and/or discontinuation of specific hormonal regimens, on genetic autoimmunity-prone background. Similar content being viewed by others

Steinman L. Immune therapy for autoimmune diseases. Science, 2004, 305: 212–6. Montanaro D, Sanna V, Matarese G, et al. The fine specificity of human T cell lines towards myelin basic protein peptides in southern Italian multiple sclerosis patients. Clin Exp Immunol 2001, 123: 288–93. Sinaii N, Cleary SD, Ballweg ML, Nieman LK, Stratton P. High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. Hum Reprod 2002, 17: 2715–24. Nothnick WB. Treating endometriosis as an autoimmune disease. Fertil Steril 2001, 2: 223–31. Matarese G, De Placido G, Nikas Y, Alviggi C. Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease? Trends Mol Med 2003, 9: 223–8. Valle RF, Sciarra JJ. Endometriosis: treatment strategies. Ann N Y Acad Sci 2003, 997: 229–39. Nepom GT, Erlich H. MHC class-II molecules and autoimmunity. Annu Rev Immunol 1991, 9: 493–525. Zetterquist H, Olerup O. Identification of the HLA-DRB1 *04, -DRB1*07, and -DRB1*09 alleles by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Hum Immunol 1992, 34: 64–74. The Americam Fertility Society. Revised American Fertility Society classification of endometriosis. Fertil Steril 1985, 3: 351–2. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001, 1: 121–7. Gallinelli A, Chiossi G, Giannella L, Marsella T, Genazzani AD, Volpe A. Different concentrations of interleukins in the peritoneal fluid of women with endometriosis: relationships with lymphocyte subsets. Gynecol Endocrinol 2004, 18: 144–151. Ota H, Igarashi S. Expression of major histocompatibility complex class II antigen in endometriotic tissue in patients with endometriosis and adenomyosis. Fertil Steril 1993, 60: 834–8. Gleicher N, el-Roeiy A, Confino E, Friberg J. Is endometriosis an autoimmune disease? Obstet Gynecol 1987, 70: 115–22. Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocrine Rev 2002, 3: 327–64. Pivonello R, De Bellis A, Faggiano A, et al. Central diabetes insipidus and autoimmunity: relationship between the occurrence of antibodies to arginine vasopressin-secreting cells and clinical, immunological, and radiological features in a large cohort of patients with central diabetes insipidus of known and unknown etiology. J Clin Endocrinol Metab 2003, 88: 1629–36. Schloot N, Eisenbarth GR. Isohormonal therapy of endocrine autoimmunity. Immunol Today 1995, 1 6: 289–94. Colao A, Pivonello R, Faggiano A, et al. Increased prevalence of thyroid autoimmunity in patients successfully treated for Cushing’s disease. Clin Endocrinol (Oxf) 2000, 53: 13–9. McGregor AM. Immunoendocrine interactions and autoimmunity. N Engl J Med 1990, 322: 1739–41. Candrina R, Di Stefano O. Exacerbation of celiac disease after cure of Cushing’s disease. Am J Med 1993, 95: 341. Steuer A, Cavan DA, Lowy C. Sarcoidosis presenting after resection of an adrenocortical adenoma. BMJ 1995, 310: 56768. Noguchi Y, Tamai H, Fujisawa K, et al. Systematic lupus erythematosus after pituitary adenomectomy in a patient with Cushing’s disease. Clin Endocrinol (Oxf) 1998, 48: 670–2. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol 2001, 2: 777–80. Whitacre CC, Reingold SC, O’Looney PA. A gender gap in autoimmunity. Science 1999, 283: 1277–8. Muller AF, Berghout A. Consequences of autoimmune thyroiditis before, during and after pregnancy. Minerva Endocrinol 2003, 28: 247–54. Hernan MA, Hohol MJ, Olek MJ, Spiegelman D, Ascherio A. Oral contraceptives and the incidence of multiple sclerosis. Neurology 2000, 55: 848–54. Thorogood M, Hannaford PC. The influence of oral contraceptives on the risk of multiple sclerosis. Br J Obstet Gynaecol 1998, 105: 1296–9. Author information Authors and Affiliations Corresponding author Rights and permissions About this article Cite this article Alviggi, C., Carrieri, P.B., Pivonello, R. et al. Association of pelvic endometriosis with alopecia universalis, autoimmune thyroiditis and multiple sclerosis. J Endocrinol Invest 29, 182–189 (2006). https://doi.org/10.1007/BF03344095 Accepted: Published: Issue date: DOI: https://doi.org/10.1007/BF03344095